ICD-10-CM Billable Code

G04.00

Acute disseminated encephalitis and encephalomyelitis, unspecified

Clinical Classification Guidelines

Medical Intelligence & Overview

Acute disseminated encephalitis (ADE) and encephalomyelitis are rare but serious neurological conditions characterized by inflammation in the brain and spinal cord. When the inflammation affects multiple areas rapidly, it is often referred to as acute disseminated encephalitis. These conditions can develop suddenly and require prompt medical attention. Although the exact cause is not always known, they are frequently associated with infections or immune responses that mistakenly attack the nervous system. Recognizing the symptoms early and understanding the potential causes can help in seeking timely treatment and managing the condition effectively.

Causes & Symptoms

Clinical Causes: Previous or ongoing infections, such as viral illnesses (e.g., herpes, influenza, measles), which can trigger immune responses attacking the nervous system. Immune system disorders, including reactions to vaccinations or autoimmune diseases where the immune system mistakenly targets neural tissue. Unknown factors, as sometimes no apparent cause can be identified. Rare genetic predispositions that may influence susceptibility.

Key Symptoms: Sudden onset of fever and headache Altered mental status, including confusion or agitation Seizures Weakness or paralysis in limbs or one side of the body Visual disturbances or loss of vision Difficulty speaking or understanding speech Loss of coordination or balance problems Sensitivity to light and sound Nausea and vomiting Alterations in consciousness, including drowsiness or coma in severe cases

Diagnostic & Treatment

Diagnosis Path: Diagnosing acute disseminated encephalitis involves a combination of clinical evaluation and specialized tests. Healthcare providers typically perform neurological examinations to assess mental status, reflexes, and motor function. Diagnostic procedures may include: - Magnetic resonance imaging (MRI): To detect areas of inflammation or damage in the brain and spinal cord. - Lumbar puncture (spinal tap): To analyze cerebrospinal fluid for signs of inflammation, abnormal cells, or antibodies. - Blood tests: To identify underlying infections or immune responses. - Electroencephalogram (EEG): To monitor electrical activity in the brain, especially if seizures occur. Since symptoms overlap with other neurological conditions, accurate diagnosis is vital for proper management.

Treatment Protocols: Treatment strategies focus on reducing inflammation and controlling symptoms. The main approaches include: - Corticosteroids: Such as high-dose prednisone or methylprednisolone to suppress immune responses and decrease inflammation. - Immunoglobulin therapy: Intravenous immunoglobulins (IVIG) may help modulate immune activity. - Plasmapheresis: A procedure to remove harmful antibodies from the blood if other treatments are ineffective. - Supportive care: This includes medications to manage seizures, pain, and other symptoms, as well as rehabilitation therapies to address neurological deficits. - Hospitalization: Often necessary for monitoring and intensive care during the acute phase. Recovery varies based on severity, and some individuals may experience long-term neurological issues despite treatment.

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is G04.00 a billable ICD-10 code?
Yes, G04.00 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report G04.00?
Clinical documentation must specify the nature of Acute disseminated encephalitis and encephalomyelitis, unspecified and any associated comorbidities for accurate reporting.

Cite this Clinical Reference

Clinical Meta Tags

acute disseminated encephalitis